Efficacy and safety of sildenafil citrate in pulmonary arterial hypertension (PAH): Results of a multinational, randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Rubin, L
Burgess, G
Parpia, T
Badesch, D
机构：
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[2] Pfizer Ltd, PGRD, Sandwich CT13 9NJ, Kent, England
[3] Univ Colorado, Hlth Sci Ctr, Dept Pulm Sci, Denver, CO USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Crit Care Med, Denver, CO USA
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2005年 / 18卷 / 05期
关键词：
exercise tolerance; pulmonary arterial hypertension; sildenafil;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：93A / 93A
页数：1
相关论文
共 50 条
  • [11] Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study
    M R Safarinejad
    A Taghva
    B Shekarchi
    Sh Safarinejad
    [J]. International Journal of Impotence Research, 2010, 22 : 325 - 335
  • [12] Efficacy and safety of inhaled nitrite in addition to sildenafil in thalassemia patients with pulmonary hypertension: A 12-week randomized, double-blind placebo-controlled clinical trial
    Sasiprapha, Thinnakrit
    Pussadhamma, Burabha
    Sibmooh, Nathawut
    Sriwantana, Thanaporn
    Pienvichit, Pavit
    Chuncharunee, Suporn
    Yingchoncharoen, Teerapat
    [J]. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2022, 120 : 38 - 43
  • [13] A placebo-controlled, double-blind trial of sildenafil citrate in women with sexual arousal disorder
    Berman, JR
    Berman, LA
    Toler, SM
    Gill, JM
    Haughie, S
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 97 - 97
  • [14] The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial
    Bose, K
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1999, 21 (03): : 209 - 213
  • [15] Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial
    Hobbs, Adrian J.
    Moyes, Amie J.
    Baliga, Reshma S.
    Ghedia, Dipa
    Ochiel, Rachel
    Sylvestre, Yvonne
    Dore, Caroline J.
    Chowdhury, Kashfia
    Maclagan, Kate
    Quartly, Harriet L.
    Sofat, Reecha
    Smit, Angelique
    Schreiber, Benjamin E.
    Coghlan, Gerry J.
    MacAllister, Raymond J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (09) : 1251 - 1267
  • [16] Tadalafil therapy in pulmonary arterial hypertension: results of a randomized, double-blind, placebo-controlled, phase III study
    Galie, N.
    Brundage, B. H.
    Ghofrani, A.
    Oudiz, R. J.
    Simonneau, G.
    Beardsworth, A.
    Chan, M.
    Barst, R. J.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 : 519 - 519
  • [17] Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
    Galie, Nazzareno
    Olschewski, Horst
    Oudiz, Ronald J.
    Torres, Fernando
    Frost, Adaani
    Ghofrani, Hossein A.
    Badesch, David B.
    McGoon, Michael D.
    McLaughlin, Vallerie V.
    Roecker, Ellen B.
    Gerber, Michael J.
    Dufton, Christopher
    Wiens, Brian L.
    Rubin, Lewis J.
    [J]. CIRCULATION, 2008, 117 (23) : 3010 - 3019
  • [18] Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
    Campillo, Jeremy T.
    Bikita, Paul
    Hemilembolo, Marlhand
    Louya, Frederic
    Missamou, Francois
    Pion, Sebastien D. S.
    Boussinesq, Michel
    Chesnais, CedricB
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 19 - 27
  • [19] Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis - A multinational, double-blind, randomized, placebo-controlled clinical trial
    Kaltwasser, JP
    Nash, P
    Gladman, D
    Rosen, CF
    Behrens, F
    Jones, P
    Wollenhaupt, J
    Falk, FG
    Mease, P
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (06): : 1939 - 1950
  • [20] A randomized, double-blind, placebo-controlled study of iloprost inhalation as add-on therapy to bosentan in pulmonary arterial hypertension (PAH)
    McLaughlin, VV
    Oudiz, R
    Frost, A
    Tapson, V
    Murali, S
    Channick, R
    Badesch, D
    Barst, R
    Hsu, H
    Rubin, L
    [J]. CHEST, 2005, 128 (04) : 160S - 160S
12345